Literature DB >> 12667245

Performance of drug resistance assays in testing HIV-1 non-B subtypes.

A Holguín1, K Hertogs, V Soriano.   

Abstract

Antiretroviral susceptibility analyses were performed in plasma samples collected from 32 HIV-1 non-B-infected individuals, most of whom had received antiretroviral drugs. Reverse transcriptase (RT) and protease gene sequences were obtained, and 15 anti-HIV drugs were tested in a recombinant virus phenotypic assay. Phenotypic results were obtained in 25 (78.1%) samples, while genotypic data were recorded in 19 (59.4%). In seven samples (21.9%), neither genotypic nor phenotypic results were obtained. Ten of 13 samples with plasma HIV RNA below 2000 copies/mL did not yield genotypic results. Resistance assays work accurately when testing HIV-1 non-B subtypes. However, as for subtype B variants, a low viral load is the most important factor limiting the application of these tests.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667245     DOI: 10.1046/j.1469-0691.2003.00521.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  2 in total

1.  Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.

Authors:  Joke Snoeck; Rami Kantor; Robert W Shafer; Kristel Van Laethem; Koen Deforche; Ana Patricia Carvalho; Brian Wynhoven; Marcelo A Soares; Patricia Cane; John Clarke; Candice Pillay; Sunee Sirivichayakul; Koya Ariyoshi; Africa Holguin; Hagit Rudich; Rosangela Rodrigues; Maria Belen Bouzas; Françoise Brun-Vézinet; Caroline Reid; Pedro Cahn; Luis Fernando Brigido; Zehava Grossman; Vincent Soriano; Wataru Sugiura; Praphan Phanuphak; Lynn Morris; Jonathan Weber; Deenan Pillay; Amilcar Tanuri; Richard P Harrigan; Ricardo Camacho; Jonathan M Schapiro; David Katzenstein; Anne-Mieke Vandamme
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  An in vitro evaluation of drugs used in the Kenyan ART program.

Authors:  Joseph Muriuki; Zipporah Ng'ang'a; Raphael Lihana; Raphael Lwembe; Joseph Mwangi; Matilu Mwau
Journal:  Pan Afr Med J       Date:  2016-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.